MétaCan
Menu
Back to cohort
Record W3155060042 · doi:10.1136/bmjopen-2020-047200

Risks and benefits of antioxidant dietary supplement use during cancer treatment: protocol for a scoping review

2021· review· en· W3155060042 on OpenAlexfundno aff
L. Susan Wieland, Ilana Moffet, Sydney Shade, Ashkan Emadi, Cheryl L. Knott, Emily Gorman

Bibliographic record

VenueBMJ Open · 2021
Typereview
Languageen
FieldNursing
TopicVitamin C and Antioxidants Research
Canadian institutionsnot available
FundersNational Center for Complementary and Integrative HealthNational Institute of Diabetes and Digestive and Kidney DiseasesNational Cancer InstituteNational Institutes of HealthOttawa Hospital Research Institute
KeywordsMedicineCINAHLCochrane LibrarySystematic reviewMEDLINEAlternative medicineMeta-analysisRandomized controlled trialIntensive care medicineInternal medicinePathologyPsychological interventionPsychiatry

Abstract

fetched live from OpenAlex

INTRODUCTION: Antioxidant dietary supplements are used by many patients with cancer to reduce the side effects of chemotherapy and improve prognosis. While some research indicates oral antioxidant supplementation reduces side effects and improves patient survival, other studies suggest the use of antioxidant dietary supplements may interfere with chemotherapy and reduce its curative effects. There is a need to clarify the evidence base on the impact of dietary antioxidant supplementation during chemotherapy on both side effect and treatment efficacy outcomes. We will use a scoping review approach to identify what systematic review evidence exists regarding beneficial and harmful effects of dietary antioxidant supplements when used during cancer treatment. METHODS AND ANALYSIS: We will use Arksey & O'Malley and Joanna Briggs Institute methods for scoping reviews. We will systematically search PubMed, Embase, CINAHL, Scopus, Dissertations & Theses Global and the Cochrane Library from inception to October 2020. Systematic reviews of randomised controlled trials of oral dietary antioxidant supplements used by participants receiving curative chemotherapy, radiotherapy or other biological therapy for cancer will be eligible. Two reviewers will screen citations and full texts for inclusion and chart data on research questions from included reviews. Two reviewers will assess the overall confidence in systematic review results using A Measurement Tool to Assess Systematic Reviews-2 (AMSTAR-2), and summarised evidence will focus on reviews rated at high or moderate overall confidence. Tables will be used to map existing evidence and identify evidence gaps for safety and effectiveness outcomes. ETHICS AND DISSEMINATION: This scoping review does not require ethical approval as it is a secondary assessment of available literature. The results will be presented at conferences and submitted for publication in a peer-reviewed journal. We will also disseminate results to community and clinical stakeholders and involve them in developing subsequent research to address critical existing gaps in the evidence as identified by the scoping review.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.082
metaresearch head score (Gemma)0.093
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Protocol · Consensus signal: Protocol
Teacher disagreement score0.101
Threshold uncertainty score0.433

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0820.093
Meta-epidemiology (narrow)0.0060.006
Meta-epidemiology (broad)0.0130.020
Bibliometrics0.0140.012
Science and technology studies0.0050.005
Scholarly communication0.0080.010
Open science0.0050.008
Research integrity0.0090.009
Insufficient payload (model declined to judge)0.1010.016

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.534
GPT teacher head0.587
Teacher spread0.054 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreProtocol

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations27
Published2021
Admission routes1
Has abstractyes

Explore more

Same venueBMJ OpenSame topicVitamin C and Antioxidants ResearchFrench-language works237,207